Jointfix Tablet is a combination pharmaceutical formulation containing Glucosamine 750 mg, Diacerein 50 mg, and Methyl Sulfonyl Methane (MSM) 250 mg, designed to support joint health and alleviate symptoms associated with osteoarthritis and other degenerative joint disorders. Glucosamine serves as a key substrate for the biosynthesis of glycosaminoglycans and proteoglycans, essential components of cartilage matrix, thereby promoting cartilage repair and maintenance. Diacerein, an anthraquinone derivative, exhibits anti-inflammatory and chondroprotective properties by inhibiting interleukin-1 beta (IL-1β), reducing cartilage degradation and improving joint function. Methyl Sulfonyl Methane acts as a sulfur donor, contributing to the synthesis of connective tissue and exhibiting antioxidant effects that may reduce oxidative stress in joint tissues. The synergistic action of these active ingredients helps reduce joint pain, stiffness, and inflammation, enhancing mobility and quality of life in patients with osteoarthritis. Jointfix Tablet is indicated for symptomatic management of mild to moderate osteoarthritis and may be used as an adjunct to physical therapy and other conventional treatments. It is recommended to be taken under medical supervision, with dosage adjustments based on clinical response and tolerability.